HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 19 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $263,000 | -57.6% | 1,143,632 | -41.0% | 0.03% | -64.6% |
| Q2 2018 | $620,000 | +31.4% | 1,938,374 | +105.8% | 0.10% | +209.7% |
| Q2 2017 | $472,000 | -26.0% | 942,011 | -19.5% | 0.03% | -8.8% |
| Q1 2017 | $638,000 | -33.5% | 1,170,793 | -15.8% | 0.03% | -39.3% |
| Q4 2016 | $960,000 | -43.2% | 1,391,286 | +2.9% | 0.06% | -11.1% |
| Q3 2016 | $1,690,000 | – | 1,351,850 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 15,834 | $6,000 | 0.00% |
| Virtu Financial LLC | 34,330 | $14,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 451,169 | $178,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 1,714 | $1,000 | 0.00% |
| Well Done, LLC | 190 | $0 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |